Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Vitamin D compounds for people with chronic kidney disease not requiring dialysis
Cochrane Reviews, 10/23/09
Palmer SC et al. – The authors identified 16 studies of vitamin D preparations in people with CKD and not requiring dialysis (less severe CKD) involving 894 people. No studies were designed to understand the effect of vitamin D therapy on risks of premature cardiovascular disease or mortality. Vitamin D agents lowered PTH significantly compared with no treatment, however also increased both calcium and phosphorus levels. Newer vitamin D therapies have not been compared with older vitamin compounds in CKD directly; whether they are associated with increased calcium and phosphorus is uncertain. In the future, new studies are required to assess outcomes important to patients, such as life expectancy and premature heart disease. It will also be important to know if vitamin D therapy should be used differently (differing target levels of PTH) in differing stages of CKD.
Related Articles
Vitamin D compounds for people with chronic kidney disease requiring dialysis
Cochrane Reviews, 10/20/09
Relevance Score: 97%
Vitamin D Metabolite-mediated Hypercalcemia With Suppressed Parathormone Concentration in Pneumocystis jiroveci Pneumonia After Kidney Transplantation
Transplantation Proceedings, 11/11/09
Relevance Score: 93%
Vitamin D deficiency and mortality
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09
Relevance Score: 93%
Vitamin B6 Metabolism in Chronic Kidney Disease - Relation to Transsulfuration, Advanced Glycation and Cardiovascular Disease
Nephron: Clinical Practice, 10/09/09
Relevance Score: 93%
Chronic kidney disease among Indigenous populations: considerations for effective and ethical research
Journal of Nephrology, 10/05/09
Relevance Score: 93%
Today in Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Homozygous SLC2A9 Mutations Cause Severe Renal Hypouricemia
Journal of the American Society of Nephrology, 11/20/09
Circulating CSF-1 Promotes Monocyte and Macrophage Phenotypes that Enhance Lupus Nephritis
Journal of the American Society of Nephrology, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


